Lipid-based formulations of antisense oligonucleotides for systemic delivery applications

Methods Enzymol. 2000:313:322-41. doi: 10.1016/s0076-6879(00)13020-4.
No abstract available

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use
  • Capsules
  • Culture Media
  • Detergents
  • Dinitrofluorobenzene
  • Drug Carriers
  • Humans
  • Inflammation
  • Liposomes
  • Lung Neoplasms / drug therapy
  • Metabolic Clearance Rate
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred ICR
  • Oligodeoxyribonucleotides, Antisense / administration & dosage*
  • Oligodeoxyribonucleotides, Antisense / pharmacokinetics*
  • Oligodeoxyribonucleotides, Antisense / therapeutic use
  • Phospholipids

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antineoplastic Agents
  • Capsules
  • Culture Media
  • Detergents
  • Drug Carriers
  • Liposomes
  • Oligodeoxyribonucleotides, Antisense
  • Phospholipids
  • Dinitrofluorobenzene